Regulation of opioid receptors by thyroliberin analogues

Balashov A.M.1, Alyabieva T.N.2, Panchenko L.F.2

1. Research Institute for Psychiatry, Ministry of Public Health
2. Research Institute for Drug Abuse, Ministry of Public Health
PubMed Id: 12498084
Year: 2002  Volume: 48  Issue: 5  Pages: 436-442
The ability of thyroliberin (TRH) to interact with opioid receptors (OR) was studied using radioligand analysis. TRH did not influence specific binding of [3H]-naloxone, but increased affinity of high affinity binding sites for the ligand in a dose-dependent manner. TRH also decreased affinity of low- affinity binding sites. Kinetic analysis of low-affinity binding sites suggests the existence of at least two subpopulations of OR, which differed in their affinity to naloxone and mode of interaction with TRH. TRH acted as non-competitive and competitive inhibitor of receptor binding sites with the lowest and moderate affinity, respectively. The allosteric pattern of TRH influence on OR with high and the lowest affinity to naloxone was suggested. TRH analogues were estimated for their ability to change in OR binding characteristics. The level of [3H]-DADL specific binding was not influenced by the peptides tested but the affinity was changed. Blind control experiment showed the ability of the TRH relative substances to increase in affinity of d-receptors could be ranked in the row: dihydroorotyl-hystidyl-prolinamide > TRH > methionyl-asparagyl-phenylalaninamide. This is consistent with ability of these compounds to influence the dopaminergic events.
Download PDF:  

Balashov, A. M., Alyabieva, T. N., Panchenko, L. F. (2002). Regulation of opioid receptors by thyroliberin analogues. Voprosy Meditsinskoi Khimii, 48(5), 436-442.
 2002 (vol 48)
 2001 (vol 47)
 2000 (vol 46)
 1999 (vol 45)
 1998 (vol 44)
 1997 (vol 43)
 1996 (vol 42)
 1995 (vol 41)
 1994 (vol 40)
 1993 (vol 39)
 1992 (vol 38)
 1991 (vol 37)
 1990 (vol 36)
 1989 (vol 35)
 1988 (vol 34)
 1987 (vol 33)
 1986 (vol 32)
 1985 (vol 31)